Peer-influenced content. Sources you trust. No registration required. This is HCN.

ReachMDChallenges in sAML Subtypes: t-AML & AML-MRC

Dr. Jonathan Abbas, Director of the Acute Leukemia and Blood Cancer Program with Tennessee Oncology in Nashville, shares key strategies and considerations for managing patients with t-AML and AML-MRC.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form